EAM
GRNAW

Empery Asset Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Empery Asset Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$21K Hold
93,837
– – 0.13% 58
2022
Q2 		$21K Hold
93,837
– – 0.11% 54
2022
Q1 		$72K Sell
93,837
-6,163
-6% -$4.51K 0.34% 37
2021
Q4 		$120K Buy
+100,000
New +$114K 0.25% 38

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Empery Asset Management's GRNAW Position: Q3 2022 in Review

Empery Asset Management held its GreenLight Biosciences Holdings, PBC Warrant (GRNAW) position steady in Q3 2022 at 93,837 shares worth $21K. The position accounts for 0.13% of the portfolio, ranked #58.

Empery Asset Management first reported a position in GRNAW in Q4 2021 and has held it in 4 quarters since. The position peaked at $120K in Q4 2021. 19 funds tracked by Wall St. Rank hold GRNAW as of Q3 2022.

  • Empery Asset Management held 93,837 shares of GreenLight Biosciences Holdings, PBC Warrant worth $21K as of Q3 2022.
  • Empery Asset Management left its GreenLight Biosciences Holdings, PBC Warrant share count unchanged in Q3 2022.
  • GreenLight Biosciences Holdings, PBC Warrant made up 0.13% of Empery Asset Management's portfolio in Q3 2022, its #58 holding.
  • Empery Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q4 2021 and has held it in 4 quarters since.
  • Empery Asset Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $120K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.